Skip to content
Global Access Atlas

Market access pathways by country

Explore how an innovative medicine moves from approval to patient access.

Selected market

Finland

Hila decides outpatient reimbursement status and a reasonable wholesale price; Kela implements patient entitlement and pharmacy payment. Hospital medicines use national/regional assessment, budgets and procurement outside Hila's community decision.

EC/EMA or national authority
applicant / organiser
applicant / Hila
Hila
Kela / pharmacy
8 decision nodes12 cited sources

For education only — not regulatory, pricing or legal advice.

About the content and how to use it